Camp Lejeune Claims in 2026: Status, Deadline and Intake

The Camp Lejeune Justice Act of 2022 gave people who lived or worked at the Marine Corps base for at least 30 days between 1953 and 1987 a federal cause of action for illnesses tied to contaminated drinking water. It is not an MDL. Every case is filed in the Eastern District of North Carolina after an administrative claim to the Navy, and four district judges manage the docket.

Intake teams should care for a reason that is the opposite of most torts. The window to file closed on August 10, 2024, and nobody can be signed as a new claimant today. What remains is a large population of already-filed claimants, many under-documented, some effectively unrepresented, and a court impatient with how slowly they are being paid.

Where the litigation stands (September 2026)

Congress passed the CLJA in August 2022 as part of the PACT Act and gave claimants two years to file. The statute requires an administrative claim with the Department of the Navy first, then a lawsuit in the Eastern District of North Carolina once the Navy denies the claim or six months pass. Judges Richard E. Myers II, Terrence W. Boyle, Louise W. Flanagan and James C. Dever III preside. The Supreme Court declined to review the jury trial question in McBrine v. United States on May 5, 2025, so every trial is a bench trial.

The Department of Justice and the Navy announced the Elective Option in September 2023. It offers fixed payments for nine qualifying illnesses, sorted into two tiers and scaled by length of exposure, with publicly reported ranges of $100,000 to $450,000 plus $100,000 in death cases. Offers expire after 60 days. As of August 10, 2026, DOJ reported offers exceeding $1 billion and payouts exceeding $827 million.

The court organized illnesses into tracks. Track 1 covers bladder cancer, kidney cancer, leukemia, non-Hodgkin lymphoma and Parkinson's disease. Track 2, designated in February 2024, covers prostate cancer, kidney disease, lung cancer, liver cancer and breast cancer. In April 2024 the government proposed a Track 3 including esophageal cancer, miscarriage, dental effects and hypersensitivity skin disorder. Track 2 and 3 work has largely waited on Track 1 rulings.

Track 1 has moved slowly. In July 2025 the court ruled that experts may rely on established science to explain causation but excluded studies or exposure models not disclosed before December 2024. In March 2026 the court struck portions of the government's expert reports. Expert discovery was essentially complete by late August 2026, and the government still contests causation for every Track 1 disease.

On July 1, 2026, the four-judge panel ordered both sides to reach a global settlement by October 30, 2026, with mandatory weekly meetings under settlement masters Thomas Perrelli and Christopher Oprison, and warned of restructuring plaintiff leadership and sanctions against DOJ if the deadline is missed. Separately, Judge Boyle set the first two kidney cancer bench trials, Mousser on November 9, 2026 and Fancher on November 16, 2026, in Elizabeth City. As of September 2026, no bellwether trial has been held.

What a qualified claimant looks like

Since no new claims can be filed, "qualified" now means a claimant with a timely administrative claim or filed lawsuit whose file can actually be paid or tried. The public record is blunt about how rare that is. The May 2026 joint status report said that among Elective Option claims carrying the bare minimum documentation, more than 88 percent still lacked sufficient evidence and fewer than 2 percent met DOJ's requirements for settlement approval.

The elements firms are checking on existing files:

• Exposure: at least 30 days at Camp Lejeune between August 1, 1953 and December 31, 1987, through residence, service, civilian employment or in utero exposure.
• A timely claim: an administrative claim submitted to the Navy on or before August 10, 2024, or a lawsuit filed in the Eastern District of North Carolina within the statutory window.
• Diagnosis: a Track 1 or Elective Option illness is the most valuable file today; Track 2 and 3 illnesses are further from resolution.
• Proof of presence: service records, muster rolls, housing, employment or dependent records placing the person on base for the qualifying period.
• Treating-provider medical records confirming the diagnosis and date, plus death certificates and estate paperwork in wrongful death cases.

Timeliness questions now turn on whether the Navy actually received an administrative claim before the deadline, whether the correct claimant was named, and whether an estate representative has authority to continue a claim for someone who has died. Those are questions for counsel. A screening team's job is to gather the paper that answers them.

Where intake goes wrong on this tort

The classic Camp Lejeune intake failure was volume without paper. Firms and vendors signed people at scale in 2022 through 2024, often by phone, with a self-reported diagnosis and date range. The government's numbers show what happened next: most claims still cannot document presence or diagnosis. A retainer with no service record and no pathology report cannot be paid under the Elective Option or tried in Track 1.

Presence is the hardest gap. Marine Corps records from the 1950s through 1980s are being digitized and produced on hard drives, and the government said in mid-2026 that muster rolls may help confirm historical presence. Until that data reaches the file, a claimant who says "I was there in 1979" has an assertion, not evidence. Adult children claiming in utero exposure depend on their parents' records.

Coached claims follow a pattern: the caller states the qualifying illness word for word, gives a date range that lands exactly on the 30-day threshold, and cannot name a treating physician or a unit. Duplicates are common because the same veteran often answered several advertisers, signed more than one retainer, and now appears on multiple rosters. Fee disputes among firms, marketers and funders followed. The August 2026 Chapter 11 filing by Galindo Law, which Law360 tied to a fee fight with a marketing company over prescreened Camp Lejeune clients, shows how that ends.

Geography also confuses screeners. Camp Lejeune, Marine Corps Air Station New River and the associated housing areas count. Other bases do not, and a veteran with several postings may honestly misremember a short one.

What acquisition looks like

There is no honest way to describe new Camp Lejeune claimant acquisition in September 2026 as a growth channel. Any campaign promising to "find new Camp Lejeune claimants" is either signing people who cannot file or re-signing people who already have counsel. Firms should treat inbound Camp Lejeune leads with that assumption until proven otherwise.

What does exist is narrower. First, claimants who filed on time and are now unrepresented, including pro se filers and clients of firms that have collapsed or exited the docket. Second, existing clients who went quiet and never returned records requests. Third, estates: a claimant who filed and has since died still has a claim, but someone has to locate the personal representative. None of this is mass advertising. It is records work, re-engagement and careful referral, inside the ethics rules on solicitation and at counsel's direction.

The audience is old, often ill and skeptical after four years of advertising. Bellwether plaintiffs have been hospitalized during the litigation, and plaintiffs' lawyers have argued for faster trials on that basis. Reaching an elderly veteran and getting a signed records release is slow, personal work that does not scale like a funnel. Firms holding a Camp Lejeune inventory should budget for documentation ahead of the October 30 deadline and the November trials, not for new lead spend.

How Slingshot screens for this tort

We are not running new claimant acquisition campaigns for Camp Lejeune, and we tell firms that when they ask. Our work on this tort is documentation and re-engagement of claimants who already filed. The four CaseLock checkpoints still apply, just to a different question: can this file be paid or tried.

Direct opt-in means the claimant, or the estate representative, personally confirms they want to proceed and consents to contact, with TCPA consent recorded. Identity verification confirms the claimant is the person named on the Navy claim, which matters because so many veterans signed with several advertisers. Document authentication is the heart of the work: we obtain service, muster, housing or employment records and treating-provider medical records, and confirm they come from the custodian rather than from a form the claimant filled out. Post-signature engagement keeps the claimant reachable through the months it takes to get 1970s Marine Corps paper into a 2026 file. A claimant who disappears after signing is the claimant the government's 88 percent figure describes.

Frequently asked questions

Can new Camp Lejeune claims still be filed in 2026?

No. The Camp Lejeune Justice Act required administrative claims to reach the Navy by August 10, 2024, and DOJ, the court's joint status reports and plaintiff firms all describe that deadline as passed. Firms should be wary of any vendor offering "new" Camp Lejeune claimants. The only paths that remain involve claims already on file, including claims an estate continues after a claimant's death. Whether any late-filing argument exists is a question for counsel.

What is the Elective Option and is it still open?

The Elective Option is the administrative settlement program DOJ and the Navy announced in September 2023 for nine qualifying illnesses. It pays fixed amounts by tier and length of exposure, publicly reported at $100,000 to $450,000 plus $100,000 in death cases, and an offer expires after 60 days. As of August 2026, DOJ reported more than $1 billion in offers and more than $827 million paid. It remains open to timely-filed claims that meet the documentation requirements, which is where most files fall short.

When will the first Camp Lejeune trial happen?

As of September 2026, no bellwether trial has been held. Judge Boyle has scheduled the first two kidney cancer bench trials for November 9 and November 16, 2026, in Elizabeth City, North Carolina. Whether they proceed may depend on the global settlement talks the four judges ordered completed by October 30, 2026. There are no jury trials under the CLJA.

Sources

This article is published by Slingshot Legal Support, a legal marketing and claimant acquisition company. It is not legal advice and does not create an attorney-client relationship. Litigation status is described as publicly reported as of the publication date and changes frequently.